In the article by Dr Ridker, this statement stood out to me..."Inflammation plays a critical role in atherosclerotic cardiovascular disease (ASCVD), a condition where the arteries become narrowed and hardened due to the buildup of plaque, which can lead to heart attacks and strokes. An analysis of three studies recently published in The Lancet found that among patients receiving statins, inflammation was a stronger predictor for risk of future cardiovascular events and death than cholesterol assessed by low-density lipoprotein cholesterol."
So why isn't anti-inflammatory, safe Vascepa used more commonly?
News 
Market Data 
Discover 
